Sonic Incytes believes in creating accessible and affordable healthtech solutions – with health insights you can count on – to improve patient care. Recognizing the rise of chronic liver disease, Sonic Incytes is on a mission to make liver health a new vital sign. Its novel, point of care ultrasound solution, Velacur, is redefining the standard of care in quantifying liver tissue stiffness and attenuation to aid in the clinical management of patients with chronic liver disease. Founded in 2017, Sonic Incytes is a health technology company headquartered in Vancouver, British Columbia, Canada.